Combined analysis of data from Taiwanese individuals for whom both data on breast cancer tissue and data on clinical hormone treatment response are available in the TCGA database has shown that hypermethylation of the gene encoding transmembrane protein gene 240 (TMEM240) is a biomarker of poor hormone therapy response in breast cancer. The gene discussed is TMEM240; the disease is breast carcinoma.